BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• BioCapital

  New Technology Shows Promise For Delivery Of Therapeutics To The Brain, Virginia Tech And Wake Forest University Study

  October 30, 2014

   · 

  2 min read
• 

  Deals

  Boston’s Rhythm Withdraws $86 Million IPO Citing Acquisition Agreement With Actavis

  October 30, 2014

   · 

  2 min read
• 

  Bio NC

  Chimerix, Inc. To Raise $105 Million To Finance Ebola Drug Trials

  October 30, 2014

   · 

  2 min read
• 

  Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG

  October 30, 2014

   · 

  1 min read
• BioMidwest

  Contamination Likely Explains “Food Genes In Blood” Claim, University of Michigan Study

  October 30, 2014

   · 

  3 min read
• 

  Policy

  Novo Nordisk A/S More Mindful On Timing Of U.S. Tresiba Launch

  October 30, 2014

   · 

  1 min read
• 

  FDA

  AstraZeneca PLC Wins FDA Approval For Two-In-One Diabetes Pill

  October 30, 2014

   · 

  2 min read
• Biotech Beach

  Saliva May Reveal Deadly Diseases Early Enough To Treat Them, University of California, Los Angeles (UCLA) Scientists Report

  October 30, 2014

   · 

  4 min read
• 

  Policy

  Amgen, Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst

  October 30, 2014

   · 

  2 min read
• 

  Business

  Sanofi Approached AstraZeneca PLC’s Soriot For CEO Role

  October 30, 2014

   · 

  2 min read